arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Abivax SA

ABVX Health Care Biotechnology: Pharmaceutical Preparations
$130.63
▲ +0.7% Today
as of Jul 22, 16:45 ET
Last 30 days +34.37% Jun 12 → Jul 22
$88.19 $103.35 $118.51 $133.67 $148.83 Jun 12 Jun 22 Jun 29 Jul 08 Jul 15 Jul 22
Open
$105.18
High
$108.16
Low
$98.23
Volume
$3M
Avg Vol
$1M
Mkt Cap
$8.0B
P/E (TTM)
—
Beta
—
52w High
$148.83
52w Low
$5.69
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 25 items

Jul 16 · 10:08 MT Newswires
Valerio Therapeutics, Abivax Enter R&D Collaboration for Inflammatory Disease Therapies
Jul 16 · 07:07 PR Business Wire
Valerio Therapeutics Announces Development Collaboration with Abivax and Provides Pipeline Update
Jul 10 · 13:55 Zacks
Should You Buy Abivax SA Sponsored ADR (ABVX) After Golden Cross?
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$5.69
$149
87% of range
Avg surprise (last 2)
+9.6%
Avg reaction (last 2)
+1.9%
50% positive
Latest IV / EM
68%
EM ±4.0% · $131 · Jul 24

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.07$-0.98$-0.89$-0.80$-0.71 Actual $-0.87Est $-0.76Actual $-0.71Est $-1.07 Mar/2025Mar/2026

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Fri May 22, 2026Mar/2026 $-0.71 $-1.07 +33.6% +18.4% -1.6% earnings
Mon Jun 2, 2025Mar/2025 $-0.87 $-0.76 -14.5% — +5.5% earnings

Implied volatility — last 90 days

48%92%136%180%224% Jun 07 — IV 122% · EM ±11.4%Jun 08 — IV 118% · EM ±9.8%Jun 09 — IV 116% · EM ±8.4%Jun 10 — IV 117% · EM ±6.9%Jun 11 — IV 113% · EM ±4.7%Jun 15 — IV 103% · EM ±7.4%Jun 16 — IV 114% · EM ±6.8%Jun 17 — IV 195% · EM ±8.2%Jun 19 — IV 156% · EM ±17.2%Jun 22 — IV 196% · EM ±16.4%Jun 23 — IV 186% · EM ±13.5%Jun 24 — IV 225% · EM ±13.3%Jun 25 — IV 207% · EM ±8.6%Jun 29 — IV 138% · EM ±32.6%Jun 30 — IV 83% · EM ±19.4%Jul 01 — IV 66% · EM ±2.8%Jul 03 — IV 72% · EM ±7.9%Jul 06 — IV 64% · EM ±5.3%Jul 07 — IV 49% · EM ±3.5%Jul 08 — IV 65% · EM ±3.8%Jul 09 — IV 72% · EM ±3.0%Jul 13 — IV 61% · EM ±5.1%Jul 14 — IV 52% · EM ±3.8%Jul 15 — IV 63% · EM ±3.7%Jul 16 — IV 125% · EM ±5.2%Jul 20 — IV 73% · EM ±6.1%Jul 21 — IV 72% · EM ±5.2%Jul 22 — IV 68% · EM ±4.0%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,162.23-0.1%
JNJ
Johnson & Johnson
$601.7B $255.02-0.2%
ABBV
AbbVie Inc.
$447.7B $256.20+1.1%
MRK
Merck & Company, Inc.
$307.2B $127.47-0.0%
PM
Philip Morris International Inc
$300.4B $195.00+0.3%
NVS
Novartis AG
$293.4B $152.73-0.2%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in